ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,216Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 32

$497K Total Retail Price of All Prescriptions

Rank: 4 out of 32

238 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 238 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 238 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,413 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 529 496 1 6
AMLODIPINE BESYLATE 440 403 2 2
RANITIDINE HCL 419 383 3 12
LISINOPRIL 399 329 4 3
POTASSIUM CHLORIDE 384 339 5 14
CHLORTHALIDONE 329 267 6 78
ATORVASTATIN CALCIUM 267 216 7 15
LEVOTHYROXINE SODIUM 260 213 8 4
FUROSEMIDE 253 199 9 5
METOPROLOL TARTRATE 243 242 10 7
BUMETANIDE 238 226 11 92
METFORMIN HCL 236 197 12 9
HYDROCHLOROTHIAZIDE 235 218 13 11
ATENOLOL 202 176 14 17
KLOR-CON M20 201 173 15 54
OMEPRAZOLE 196 151 16 8
METOPROLOL SUCCINATE 164 115 17 18
NAPROXEN 140 131 18 72
HYDROCODONE-ACETAMINOPHEN 140 122 S3 18 1
COUMADIN 138 133 20 70
CRESTOR 135 104 21 21
POLYETHYLENE GLYCOL 3350 125 106 22 46
DIGOXIN 122 121 23 56
AMLODIPINE BESYLATE-BENAZEPRIL 115 85 24 55
INSULIN SYRINGE 110 94 25 75
CARVEDILOL 110 101 25 28
PHENYTOIN SODIUM EXTENDED 105 52 27 102
PRAVASTATIN SODIUM 105 89 27 10
ALLOPURINOL 99 91 29 26
CLOPIDOGREL 92 90 30 38
LEVETIRACETAM 90 65 31 74
METFORMIN HCL ER 88 55 32 36
LANTUS 87 87 33 29
ZOLPIDEM TARTRATE 84 63 34 20
BENAZEPRIL HCL 83 58 35 88
DIOVAN 81 81 36 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 52 37 19
ISOSORBIDE MONONITRATE ER 75 75 38 49
FLUTICASONE PROPIONATE 75 55 38 58
RISPERIDONE 73 58 40 39
PANTOPRAZOLE SODIUM 73 67 40 75
COLCRYS 72 67 42 73
TAMSULOSIN HCL 72 72 42 34
METOCLOPRAMIDE HCL 69 69 44 93
CIPROFLOXACIN HCL 66 54 45 35
AZITHROMYCIN 65 46 46 32
SINGLE USE SWAB 64 61 47 118
PLAVIX 63 60 48 64
WARFARIN SODIUM 63 57 48 25
FAMOTIDINE 61 61 50 47
NEXIUM 60 39 51 23
NOVOLOG MIX 70-30 58 34 52 171
CAPTOPRIL 58 43 52 171
TRAMADOL HCL 51 41 54 13
KLOR-CON M10 50 50 55 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.